Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2010

Open Access 01-12-2010 | Research

HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection

Authors: Amel AM Elfaramawy, Reham M Elhossiny, Amal A Abbas, Heba M Abdel Aziz

Published in: Italian Journal of Pediatrics | Issue 1/2010

Login to get access

Abstract

Background

The human leukocyte antigens (HLAs) are proteins found in the membranes of nearly all nucleated cells. People with certain HLA antigens are more likely to develop certain autoimmune diseases. The aim of this study was to determine the frequency of HLA-DRB1 in children with autoimmune hepatitis (AIH) as a risk factor for occurrence, its relation to preceding hepatitis A infection and treatment outcome.

Subjects and methods

25 children with AIH were subjected to HLA-DRB 1 typing performed by sequence specific oligonucleotide probe technique and compared to HLA-DRB1 found in 548 normal populations.

Results

The most frequent alleles found in our children with AIH were HLA-DRB1*13 (36%), HLA-DRB1*04 (18%) and HLA-DRB1*03 (14%). HLA-DRB1*13 was significantly more frequent in AIH patients compared to controls. In type I AIH patients HLA-DRB1*13 was the most frequent allele (32.4%), followed by HLA-DRB1*04 in (20.6%) and HLA-DRB1*03 in (14.7%), While in type II, the most frequent alleles were HLA-DRB1*13 in (40%), HLA-DRB1*07 (20%) and HLA-DRB1*15 in (20%). HLA-DRB1*12 was significantly more frequent in AIH patients with positive Hepatitis A IgM than in patients with negative hepatitis A IgM. No statistically significant difference between partial responders and complete responders to treatment as regards HLA-DRB1 subtypes.

Conclusion

It is concluded from the previous study that HLA-DRB1*13 may be a susceptibility allele for the occurrence of autoimmune hepatitis in our population. HLA-DRB1*07 and HLA-DRB1*15 may be susceptibility alleles for occurrence of autoimmune hepatitis type 2. HLA-DRB1*12 association with AIH in patients triggered by hepatitis A needs further studies.
Literature
1.
go back to reference Manns MP, Vogel A: Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006, 43: S132-S144. 10.1002/hep.21059.PubMedCrossRef Manns MP, Vogel A: Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006, 43: S132-S144. 10.1002/hep.21059.PubMedCrossRef
2.
go back to reference Czaja AJ, Norman GL: Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol. 2003, 37: 315-329. 10.1097/00004836-200310000-00011.PubMedCrossRef Czaja AJ, Norman GL: Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol. 2003, 37: 315-329. 10.1097/00004836-200310000-00011.PubMedCrossRef
4.
go back to reference Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alveraz F: Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J hepatolo. 2004, 40 (6): 904-909. 10.1016/S0168-8278(04)00097-2.CrossRef Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alveraz F: Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J hepatolo. 2004, 40 (6): 904-909. 10.1016/S0168-8278(04)00097-2.CrossRef
5.
go back to reference Sheldon S, Poulton K: HLA typing and its influence on organ transplantation. Methods Mol Biol. 2006, 333: 157-174.PubMed Sheldon S, Poulton K: HLA typing and its influence on organ transplantation. Methods Mol Biol. 2006, 333: 157-174.PubMed
6.
go back to reference Thorsby E, Lie BA: HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol. 2005, 14 (3-4): 175-82. 10.1016/j.trim.2005.03.021.PubMedCrossRef Thorsby E, Lie BA: HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol. 2005, 14 (3-4): 175-82. 10.1016/j.trim.2005.03.021.PubMedCrossRef
7.
go back to reference Czaja AJ, Carpenter HA, Moore B: HLA-DRB1*13 as a risk factor for Type I Autoimmune Hepatitis in North American Patients. Dig dis sci. 2007, 53: 522-528. 10.1007/s10620-007-9859-4.PubMedCrossRef Czaja AJ, Carpenter HA, Moore B: HLA-DRB1*13 as a risk factor for Type I Autoimmune Hepatitis in North American Patients. Dig dis sci. 2007, 53: 522-528. 10.1007/s10620-007-9859-4.PubMedCrossRef
8.
go back to reference Hilzenrat N, Zilberman D, Klien T, Zur B, Sikuler E: Autoimmune Hepatitis in a genetically susceptible patient: Is it triggered by acute viral hepatitis A?. Dig Dis Sci. 1999, 44 (10): 1950-1952. 10.1023/A:1026645629103.PubMedCrossRef Hilzenrat N, Zilberman D, Klien T, Zur B, Sikuler E: Autoimmune Hepatitis in a genetically susceptible patient: Is it triggered by acute viral hepatitis A?. Dig Dis Sci. 1999, 44 (10): 1950-1952. 10.1023/A:1026645629103.PubMedCrossRef
9.
go back to reference Alvarez F, Berg PA, Bianchi FB: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31 (5): 929-38. 10.1016/S0168-8278(99)80297-9.PubMedCrossRef Alvarez F, Berg PA, Bianchi FB: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31 (5): 929-38. 10.1016/S0168-8278(99)80297-9.PubMedCrossRef
10.
go back to reference Saiki RK, Walsh PS, Levenson CH: Genetic analysis of amplified DNA with immobilized sequence specific oligonucleotide probes. Proc Nat Acad Sci. 1989, 86: 6230-10.1073/pnas.86.16.6230.PubMedCentralPubMedCrossRef Saiki RK, Walsh PS, Levenson CH: Genetic analysis of amplified DNA with immobilized sequence specific oligonucleotide probes. Proc Nat Acad Sci. 1989, 86: 6230-10.1073/pnas.86.16.6230.PubMedCentralPubMedCrossRef
11.
go back to reference Khalil R, El Kafrawy H, Shoukeir M: Frequency of human leucocyte antigens in a sector of the Egyptian population. Az J Microbiol. 2000, 49: 111- Khalil R, El Kafrawy H, Shoukeir M: Frequency of human leucocyte antigens in a sector of the Egyptian population. Az J Microbiol. 2000, 49: 111-
12.
go back to reference Krawitt EL: Autoimmune hepatitis. N Engl J Med. 2006, 354 (1): 5466-10.1056/NEJMra050408.CrossRef Krawitt EL: Autoimmune hepatitis. N Engl J Med. 2006, 354 (1): 5466-10.1056/NEJMra050408.CrossRef
13.
go back to reference Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997, 25: 317-323. 10.1002/hep.510250211.PubMedCrossRef Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997, 25: 317-323. 10.1002/hep.510250211.PubMedCrossRef
16.
go back to reference Muratori P, granite A, Quarneti C, Ferri S, Menichella R, Cassani F, Pappas G, Bianchi FB, Lenzi M, Muratori L: Autoimmune hepatitis in Italy: The Bologna experience. J Hepatol. 2009, 50: 1210-1218. 10.1016/j.jhep.2009.01.020.PubMedCrossRef Muratori P, granite A, Quarneti C, Ferri S, Menichella R, Cassani F, Pappas G, Bianchi FB, Lenzi M, Muratori L: Autoimmune hepatitis in Italy: The Bologna experience. J Hepatol. 2009, 50: 1210-1218. 10.1016/j.jhep.2009.01.020.PubMedCrossRef
17.
go back to reference Mieli-Vergani G, Vergani D: Auto-immune hepatitis. Liver Disease in Children. Edited by: Suchy FJ, Sokol RJ, Balistreri WF. 2007, Lippincott Williams and Wilkins, Ch 18: 447-458. full_text. 3CrossRef Mieli-Vergani G, Vergani D: Auto-immune hepatitis. Liver Disease in Children. Edited by: Suchy FJ, Sokol RJ, Balistreri WF. 2007, Lippincott Williams and Wilkins, Ch 18: 447-458. full_text. 3CrossRef
18.
go back to reference Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y: Prognosis of symptomatic versus asymptomatic autoimmune hepatitis. A study of 68 patients. J Clin Gastroenterol. 2002, 35: 75-81. 10.1097/00004836-200207000-00016.PubMedCrossRef Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y: Prognosis of symptomatic versus asymptomatic autoimmune hepatitis. A study of 68 patients. J Clin Gastroenterol. 2002, 35: 75-81. 10.1097/00004836-200207000-00016.PubMedCrossRef
19.
go back to reference Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani F, Chiodo F, Bianchi FB: Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the acute type. QJM. 2004, 97: 407-412. 10.1093/qjmed/hch072.PubMedCrossRef Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani F, Chiodo F, Bianchi FB: Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the acute type. QJM. 2004, 97: 407-412. 10.1093/qjmed/hch072.PubMedCrossRef
20.
go back to reference Manns M, Griffin KJ, Sullivan KD, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a Cytochrome P-450 Monooxygenase. J Clin Invest. 1991, 88: 1370-8. 10.1172/JCI115443.PubMedCentralPubMedCrossRef Manns M, Griffin KJ, Sullivan KD, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a Cytochrome P-450 Monooxygenase. J Clin Invest. 1991, 88: 1370-8. 10.1172/JCI115443.PubMedCentralPubMedCrossRef
21.
go back to reference Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D: Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type1 susceptible individuals. Lancet. 1991, 337: 1183-7. 10.1016/0140-6736(91)92858-Y.PubMedCrossRef Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D: Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type1 susceptible individuals. Lancet. 1991, 337: 1183-7. 10.1016/0140-6736(91)92858-Y.PubMedCrossRef
22.
go back to reference Urganci N, Akyildiz B, Yildirmak Y, Ozbay G: A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection. Turkish J Gastroenterol. 2003, 14 (3): 204-207. Urganci N, Akyildiz B, Yildirmak Y, Ozbay G: A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection. Turkish J Gastroenterol. 2003, 14 (3): 204-207.
23.
go back to reference Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R: Autoimmune hepatitis induced by the prolonged hepatitis A virus infection, case report. Annals of Hepatology. 2008, 7 (2): 177-179.PubMed Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R: Autoimmune hepatitis induced by the prolonged hepatitis A virus infection, case report. Annals of Hepatology. 2008, 7 (2): 177-179.PubMed
25.
go back to reference Bittencourt PL, Farias AQ, Porta G, Cançado ELR, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ: Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis effect of age, gender, and genetic background. J Clin Gastroenterol. 2008, 42 (3): 300-305.PubMed Bittencourt PL, Farias AQ, Porta G, Cançado ELR, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ: Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis effect of age, gender, and genetic background. J Clin Gastroenterol. 2008, 42 (3): 300-305.PubMed
26.
go back to reference Miyake Y, Yamamoto K: current status of autoimmune hepatitis in Japan. Acta Med Okayama. 2008, 62 (4): 217-226. Miyake Y, Yamamoto K: current status of autoimmune hepatitis in Japan. Acta Med Okayama. 2008, 62 (4): 217-226.
27.
go back to reference Fainboim L, Cañero Velasco MC, Marcos CY, Ciocca M, Roy A, Theiler G, Capucchio M, Nuncifora S, Sala L, Zelazko M: Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB1* 1301, a marker for pediatric autoimmune hepatitis. Hepatology. 2001, 33 (6): 1512-1517. 10.1053/jhep.2001.24562.PubMedCrossRef Fainboim L, Cañero Velasco MC, Marcos CY, Ciocca M, Roy A, Theiler G, Capucchio M, Nuncifora S, Sala L, Zelazko M: Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB1* 1301, a marker for pediatric autoimmune hepatitis. Hepatology. 2001, 33 (6): 1512-1517. 10.1053/jhep.2001.24562.PubMedCrossRef
28.
go back to reference Montano-Loza AJ, Carpenter HA, Czaja AJ: Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end stage liver disease. Hepatology. 2007, 46 (4): 1138-1145. 10.1002/hep.21787.PubMedCrossRef Montano-Loza AJ, Carpenter HA, Czaja AJ: Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end stage liver disease. Hepatology. 2007, 46 (4): 1138-1145. 10.1002/hep.21787.PubMedCrossRef
Metadata
Title
HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection
Authors
Amel AM Elfaramawy
Reham M Elhossiny
Amal A Abbas
Heba M Abdel Aziz
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2010
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/1824-7288-36-73

Other articles of this Issue 1/2010

Italian Journal of Pediatrics 1/2010 Go to the issue